Rapamycin vs 17-alpha-estradiol
Written by Aaron CuhaReviewed Sep 2026
The short answer
Two compounds that reliably make mice live longer in the same program run at several sites. One of them only works in males. 17-alpha-estradiol does not work in females and nobody knows why. That kind of detail disappears when results are summed up as longer life.
- Rapamycin people
- 25
- Rapamycin nulls
- 0
- 17-alpha-estradiol people
- 0
- 17-alpha-estradiol nulls
- 0
Dose
Approved medicine. No human dose established for unlabelled uses
Labeled amounts sit on the prescribing information. This page records what trials measured, not a personal dose.
FDA-approved (Rapamune); use for longevity is off-label (not what it is approved for) and investigational
Dose
No human dose established
No published study on this page has given this compound to people and reported a result.
4 animal studies, no human study
First-hand reports are counted on each profile and never added together. This page sets two published records side by side. It does not pick a winner.
Column A
RapamycinRapamycin (Sirolimus, mTOR inhibitor)
An approved drug that blocks mTOR, a growth switch in cells. It makes many kinds of animals live longer. Some people take low, spaced-out doses for ageing, off-label. Studies in people are small.
Column B
17-alpha-estradiol17-alpha-estradiol, non-feminising estradiol stereoisomer
In male mice, it has made them live longer again and again, even at higher doses and even when started late in life. It does nothing for female mice, and nobody knows why.
Side by side, on the facts we can check
| What we compare | Rapamycin | 17-alpha-estradiol |
|---|---|---|
| Category | Longevity | Longevity |
| FDA status | FDA-approved (Rapamune); use for longevity is off-label (not what it is approved for) and investigational | Not approved in the United States for any use. Some European countries sell it as a scalp treatment for pattern hair loss. That is a different use, a different way of taking it and a different dose from the lifespan studies. |
| Half-life | ~60 hours | Not asserted for the mouse dosing regimen. It is fed in the diet in these studies, so exposure is continuous rather than pulsed. |
| Molecular weight | 914.2 Da | 272.4 Da. A steroid, not a peptide. |
| How it works | It blocks the mTOR pathway. That copies part of what eating less does to cells, and it boosts cell clean-up and upkeep. | It is the mirror-image form of normal estradiol. That small flip makes it far weaker at the usual estrogen receptors, so it loses the feminising effects. Because it is not acting like a normal estrogen, nobody knows how it makes mice live longer. Reported effects in mice include less inflammation in the hypothalamus, a brain area that runs hunger and hormones. They also include a better insulin response in the liver, less mTOR growth signalling in the liver, and better metabolic health markers. The male-only result is the heart of the puzzle. If it worked through a route that has nothing to do with hormones, there is no clear reason it would fail in females. But it does fail in females. |
| Studies in people | 3 | 0 |
| Evidence | Limited: 2 completed trials, 25 people given it | Animal or lab only: 4 animal studies, no human study |
| Legal status, US | FDA-approved (for its labeled use), prescription only | Not approved; research use only |
Frequently asked questions
What is the difference between Rapamycin and 17-alpha-estradiol?
Rapamycin: An approved drug that blocks mTOR, a growth switch in cells. It makes many kinds of animals live longer. Some people take low, spaced-out doses for ageing, off-label. Studies in people are small. 17-alpha-estradiol: In male mice, it has made them live longer again and again, even at higher doses and even when started late in life. It does nothing for female mice, and nobody knows why.
Which has stronger research evidence, Rapamycin or 17-alpha-estradiol?
Each compound gets a band worked out from facts we counted, with the math shown. Rapamycin is Limited (2 completed trials, 25 people given it). 17-alpha-estradiol is Animal or lab only (4 animal studies, no human study). That counts how much has been done in people. It does not rate whether either one works, and neither one is called the winner.
Are Rapamycin and 17-alpha-estradiol FDA-approved?
Rapamycin: FDA-approved (Rapamune); use for longevity is off-label (not what it is approved for) and investigational. 17-alpha-estradiol: Not approved in the United States for any use. Some European countries sell it as a scalp treatment for pattern hair loss. That is a different use, a different way of taking it and a different dose from the lifespan studies..
Related posts
Blog articles that cover Rapamycin or 17-alpha-estradiol, newest first.
- Longevity / Sep 27, 2026 / 12 minPeptides for Longevity: What the Evidence Actually Shows in 2026
- Longevity / Sep 27, 2026 / 9 minSenolytics in 2026: Dasatinib plus Quercetin, Fisetin, and What Human Trials Have Shown
- Longevity / Sep 27, 2026 / 9 minThe Rapamycin Dosing Debate: What PEARL Tested, the Bioavailability Problem, and What Is Unproven
Reviewed Sep 2026. This page puts two published records side by side. It is for learning, and it is not medical advice. When this site shows a dose, it is the dose a trial or a clinic actually used, or what people say they did, with the source attached. None of it tells you what to take.